financetom
Business
financetom
/
Business
/
Trump says US wants to make tanks, not T-shirts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump says US wants to make tanks, not T-shirts
May 26, 2025 1:46 PM

MORRISTOWN, New Jersey, May 25 (Reuters) - U.S.

President Donald Trump said on Sunday his tariff policy was

aimed at promoting the domestic manufacturing of tanks and

technology products, not sneakers and T-shirts.

Speaking to reporters before boarding Air Force One in New

Jersey, Trump said he agreed with comments from Treasury

Secretary Scott Bessent on April 29 that the U.S. does not

necessarily need a "booming textile industry" - comments that

drew criticism from the National Council of Textile

Organizations.

"We're not looking to make sneakers and T-shirts. We want to

make military equipment. We want to make big things. We want to

do the AI thing with computers," Trump said.

"I'm not looking to make T-shirts, to be honest. I'm not

looking to make socks. We can do that very well in other

locations. We are looking to do chips and computers and lots of

other things, and tanks and ships," Trump said.

Trump, who has upended world markets with the broad

imposition of tariffs, revived his harsh trade rhetoric on

Friday when he pushed for a 50% tariff on European Union goods

starting June 1 and warned Apple ( AAPL ) he may impose a 25%

levy on all imported iPhones bought by U.S. consumers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dogwood Therapeutics Enrolls 100 in Halneuron Study for Chemo-Related Pain
Dogwood Therapeutics Enrolls 100 in Halneuron Study for Chemo-Related Pain
Nov 11, 2025
03:12 PM EST, 11/11/2025 (MT Newswires) -- Dogwood Therapeutics ( DWTX ) enrolled the first 100 patients in its Phase 2b study evaluating Halneuron for chemotherapy-induced neuropathic pain. An interim analysis is scheduled for Q4 based on participants who complete or exit the four-week trial, the company said Tuesday in a statement. The study remains on track to recruit 200...
Market Chatter: Centerspace Explores Options Including Potential Sale
Market Chatter: Centerspace Explores Options Including Potential Sale
Nov 11, 2025
03:13 PM EST, 11/11/2025 (MT Newswires) -- Centerspace ( CSR ) is exploring options including a potential sale, Bloomberg reported Tuesday, citing people familiar with the matter. The real estate company is said to be working with advisors as it fields takeover interest, Bloomberg said, adding that the talks are at an early stage and the company can decide to...
MDU Resources Signs MOU for 150 MW Capacity in North Plains Connector Project
MDU Resources Signs MOU for 150 MW Capacity in North Plains Connector Project
Nov 11, 2025
03:18 PM EST, 11/11/2025 (MT Newswires) -- MDU Resources ( MDU ) joined the North Plains Connector utility consortium through a nonbinding memorandum of understanding with North Plains Connector, a Grid United subsidiary, the companies said Tuesday. The agreement gives MDU Resources ( MDU ) 150 megawatts of capacity on the planned 3,000-megawatt, 420-mile high-voltage direct current transmission line connecting...
Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India
Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India
Nov 11, 2025
Novo Nordisk A/S ( NVO ) shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc ( MTSR ) . What Happened: According to Reuters, Pfizer Inc ( PFE ) won the bidding war against Novo Nordisk ( NVO ) and will purchase Metsera ( MTSR ) for $10 billion. The board of Metsera...
Copyright 2023-2026 - www.financetom.com All Rights Reserved